InMed Pharmaceuticals Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q2 2021 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
InMed Pharmaceuticals Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2021 to Q2 2022.
  • InMed Pharmaceuticals Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending June 30, 2022 was $18.7M, a 33.7% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $18.7M +$4.71M +33.7% Jun 30, 2022 10-K 2022-09-23
Q2 2021 $14M Jun 30, 2021 10-K 2022-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.